Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus

Journal of Clinical Investigation

Volumn 101, Issue 2, 1998, Pages 503-510

  Jensen, Per B ^b   Blume, Niels ^b   Mikkelsen, Jens D ^a   Larsen, Philip J ^a   Jensen, Heidi I ^b   Holst, Jens J ^a   Madsen, Ole D ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HAGEDORN RESEARCH INSTITUTE   (Denmark)

Author keywords

Cancer; GLP 1; Glucagon; Hunger regulation; Leptin

Indexed keywords

LEPTIN; MESSENGER RNA; NEUROPEPTIDE Y; PROGLUCAGON;

ADIPSIA; ANIMAL CELL; ANIMAL TISSUE; ANOREXIA; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GLUCAGONOMA; MALE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SATIETY;

EID: 0032518563     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI275     Document Type: Article

References (78)

1. Madsen, O.D., L.C. Andersen, B. Michelsen, D. Owerbach, L.I. Larsson, Å. Lernmark, and D.F. Steiner. 1988. Tissue-specific expression of transfected human insulin genes in pluripotent rat insulinoma lines induced during passage in vivo. Proc. Natl. Acad. Sci. USA. 85:6652-6656.
2. Madsen, O.D., C. Karlsen, E. Nielsen, K. Lund, H. Kofod, B. Welinder, J.F. Rehfeld, L.I. Larsson, D.F. Steiner, J.J. Holst, and B.K. Michelsen. 1993. The dissociation of tumor-induced weight loss from hypoglycemia in a transplantable rat islet tumor results in the segregation of stable α-and β-cell tumor phenotypes. Endocrinology. 133:2022-2030.
3. Madsen, O.D., C. Karlsen, N. Blume, H. Jensen, L.I. Larsson, and J. Hoslt. 1995. Transplantable glucagonomas derived from pluripotent rat islet tumor tissue cause severe anorexia and adipsia. Scand. J. Clin. Lab. Invest. Suppl. 220:27-36.
4. Blume, N., J. Skouv, L.I. Larsson, J.J. Holst, and O.D. Madsen. 1995. Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis. J. Clin. Invest. 96:2227-2235.
5. Mordes, J.P., and A.A. Rossini. 1981. Tumor-induced anorexia in the wistar rat. Science. 213:565-567.
6. Norton, J.A., J.F. Moley, M.V. Green, R.E. Carson, and S.D. Morrison. 1985. Parahiotic transfer of cancer anorexia/cachexia in male rats. Cancer Res. 45:5547-5552.
7. Illig, K.A., N. Maronian, and J.L. Peacock. 1992. Cancer cachexia is transmissible in plasma. J. Surg. Res. 52:353-358.
8. Brubaker, P.L., Y.C. Lee, and D.J. Drucker. 1992. Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigene gene. J. Biol. Chew. 267:20728-20733.
9. Ehrlich, P., D. Tucker, S.L. Asa, P.L. Brubaker, and D.J. Drucker. 1994. Inhibition of pancreatic proglucagon gene expression in mice bearing subcutaneous endocrine tumors. Am. J. Physiol. 30:E662-E671.
10. Holst, J.J. 1985. Glucagon-producing tumors. In Hormone Producing Tumors of the Gastrointestinal Tract. S. Cohen, editor. Churchill Livingstone, New York. 57-84.
11. Bhathena, S.J., G.A. Higgins, and L. Recant. 1981. Glucagonoma and glucagonoma syndrome. In Glucagon. Physiology, Pathophysiology and Morphology of the Pancreatic A-cells. R.H. Unger and L. Orci, editors. Elsevier, New York. 413-438.
12. Tisdale, M.J. 1993. Cancer cachexia. Anticancer Drugs. 4:115-125.
13. Nelson, K.A., D. Walsh, and F.A. Sheehan. 1994. The cancer anorexiacachexia syndrome. J. Clin. Oncol. 12:213-225.
14. McDevitt, T.M., P.T. Todorov, S.A. Beck, S.H. Kahn, and M.J. Tisdale. 1995. Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans. Cancer Res. 55:1458-1463.
15. Stanley, B.G., S.E. Kyrkouli, S. Lampert, and S.F. Leibowitz. 1986. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides. 7:1189-1192.
16. Paez, X., and R.D. Myers. 1991. Insatiable feeding evoked in rats by recurrent perfusion of neuropeptide Y in the hypothalamus. Peptides. 12:609-616.
17. Roscoe, A.K., and R.D. Myers. 1991. Hypothermia and feeding induced simultaneously in rats by perfusion of neuropeptide Y in preoptic area. Pharmacol. Biochem. Behav. 39:1003-1009.
18. Bai, F.L., M. Yamano, Y. Shiotani, P.C. Emson, A.D. Smith, J.F. Powell, and M. Tohyama. 1985. An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenalin in the rat. Brain Res. 331:172-175.
19. Kalra, S.P., M.G. Dube, A. Sahu, C.P. Phelps, and P.S. Kalra. 1991. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc. Natl. Acad. Sci. USA. 88:10931-10935.
20. Akabayashi, A., C. Wahlestedt, J.T. Alexander, and S.F. Leibowitz. 1994. Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. Brain Res. 21:55-61.
21. Beck, B., U.M. Jhanwar, A. Burlet, C.M. Chapleur, S.F. Leibowitz, and C. Burlet. 1990. Rapid and localized alterations of neuropeptide Y in discrete hypothalamic nuclei with feeding status. Brain Res. 528:245-249.
22. Sanacora, G., M. Kershaw, J.A. Finkelstein, and J.D. While. 1990. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology. 127:730-737.
23. Davies, L., and J.L. Marks. 1994. Role of hypothalamic neuropeptide Y gene expression in body weight regulation. Am. J. Physiol. 266:R1687-R1691.
24. Pesonen, U., R. Huupponen, J. Rouru, and M. Koulu. 1992. Hypothalamic neuropeptide expression after food restriction in Zucker rats: evidence of persistent neuropeptide Y gene activation. Mol. Brain Res. 16:255-260.
25. Schwartz, M.W., J.L. Marks, A.J. Sipols, D.G. Baskin, S.C. Woods, S.E. Kahn, and D. Porte. 1991. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology. 128:2645-2647.
26. Beck, B., A. Burlet, R. Bazin, J. Nicolas, and C. Burlet. 1993. Elevated neuropeptide Y in the arcuate nucleus of young obese Zucker rats may contribute to the development of their overeating. J. Nutr. 123:1168-1172.
27. Williams, G., J.S. Gill, Y.C. Lee, H.M. Cardoso, B.E. Okpere, and S.R. Bloom. 1989. Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozotocin-induced diabetic rats. Diabetes. 38:321-327.
28. White, J.D., D. Olchovsky, M. Kershaw, and M. Berelowitz. 1990. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats. Endocrinology. 126:765-772.
29. Abe, M., S. Masasyuki, H. Ikeda, and T. Shimazu. 1991. Increased neuropeptide Y content in the arcuato-paraventricular hypothalamic neuronal system in both insulin-dependent and non-insulin-dependent diabetic rats. Brain Res. 539:223-227.
30. Sahu, A., C.A. Sninsky, C.P. Phelps, M.G. Dube, P.S. Kalra, and S.P. Kalra. 1992. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. Endocrinology. 131:2979-2985.
31. Zhang, Y., R. Proenca, M. Maffai, M. Barone, L. Leopold, and J.M. Friedman. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425-432.
32. Wilding, J.P.H., S.G. Gilbey, C.J. Baileym R.A. Batt, G. Williams, M.A. Ghatei, and S.R. Bloom. 1993. Increased neuropeptide Y messenger RNA and decreased neurotensin messenger RNA in the hypothalamus of the obese (ob/ ob) mouse. Endocrinology. 132:1939-1944.
33. Halaas, L.L., K.S. Gajiwala, M. Maffei, S.L. Cohen, B.T. Chait, D. Rabinowitz, R.L. Lallone, S.K. Burley, and J.M. Friedman. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269: 543-546.
34. Pellymounter, M.A., M.J. Cullen, M.B. Baker, R. Hecht, D. Winters, T. Brone, and F. Collins. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269:540-543.
35. Campfield, A.L., F.J. Smith, Y. Guisez, R. Devos, and P. Burn. 1995. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural network. Science. 269:546-549.
36. Stephens, T.W., M. Basinski, P.K. Bristow, J.M. Bue-Valleskey, S.G. Burgett, L. Craft, J. Hale, J. Hoffmann, H.M. Hsiung, A. Kriausiunas, et al. 1995. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 377:530-532.
37. Schwartz, M.W., D.G. Baskin, T.R. Bukowski, J.L. Kuijper, D. Foster, G. Lasser, D.E. Prunkard, D. Porte, S.C. Woods, R.J. Seeley, et al. 1996. Specificity of leptin action on elevated Mood-glucose levels and hypothalamic neuropeptide-Y gene-expression in ob/ob mice. Diabetes. 45:531-535.
38. Holst, J.J. 1983. Evidence that peak II GLI or enteroglucagon is identical to the C-terminal sequence (residues 33-69) of glicentin. Biochem. J. 207: 381-388.
39. Orskov, C., J. Jeppesen, S. Madsbad, and J.J. Holst. 1991. Proglucagon products in plasma of non-insulin-dependent diabetics and nondiabetic controls in the fasting state and following oral glucose and intravenous arginine. J. Clin. Invest. 87:415-123.
40. Madsen, O.D., L.I. Larsson, J.F. Rehfeld, T. Schwartz, A. Lernmark, A. Labrecque, and D.F. Steiner. 1986. Cloned cell lines from a transplantable insulinoma are heterogeneous and express cholecystokinin in addition to islet hormones. J. Cell Biol. 103:2025-2034.
41. Larsen, P.J., J.D. Mikkelsen, D.S. Jessop, S.L. Lightman, and H.S. Chowdrey. 1993. Neuropeptide Y mRNA and immunoreactivity in hypothalamic neuroendocrine neurons: effects of adrenalectomy and chronic osmotic stimulation. J. Neurosci. 13:1138-1147.
42. Minth, C.D., P.C. Andrews, and J.E. Dixon. 1986. Characterization, sequence, and expression of the cloned human neuropeptide Y gene. J. Biol. Chem. 261:11974-11979.
43. Larhammer, D., A. Ericsson, and H. Persson. 1987. Structure and expression of the rat neuropeptide Y gene. Proc. Natl. Acad. Sci. USA. 84:2068-2072.
44. Murakami, T., and K. Shima. 1995. Cloning of rat obese cDNA and its expression in obese rats. Biochem. Biophys. Res. Commun. 209:944-952.
45. Oliff, A., D. Defeo-Jones, M. Boyer, D. Martinez, D. Kiefer, G. Vuocofo, A. Wolfe, and S. Socher. 1987. Tumor secreting human TNF/cachectin induce cachexia in mice. Cell. 50:555-563.
46. Coleman, D.L. 1973. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia. 9:294-298.
47. Chua, S.C., W.K. Chung, X.S. Wupeng, Y.Y. Zhang, S.M. Liu, L. Tartaglia, and R.L. Leibel. 1996. Phenotypes of mouse diabetes and rat fatty due to mutations in the ob (leptin) receptor. Science. 271:994-996.
48. Lee, G.H., R. Proenca, J.M. Montez, K.M. Carroll, J.G. Darvishzadeh, J.I. Lee, and J.M. Friedman. 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature, 379:632-635.
49. Chen, H., O. Charlat, L.A. Tartaglia, E.A. Woolf, X. Weng, S.J. Ellis, N.D. Lakey, J. Culpepper, K.J. Moore, R.E. Breitbart, et al. 1996. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell. 84:491-495.
50. Geary, N. 1990. Pancreatic glucagon signals postprandial satiety. Nurosci. Biobehav. Rev. 14:323-338.
51. Geary, N., J.L. Sauter, and U. Noh. 1993. Glucagon acts in the liver to control spontaneous meal size in rats. Am. J. Physiol. 264.-R116-R122.
52. Sauter, J.L., U. Noh, and N. Geary. 1991. Hepatic portal infusions of glucagon antibodies increases spontaneous meal size in rats. Am. J. Physiol. 261:R162-R165.
53. Nishimura, E., N. Abrahamsen, L.H. Hansen, K. Lundgren, and O. Madsen. 1996. Regulation of glucagon receptor expression. Acta Physiol. Scand. 157:329-332.
54. 2 in the central control of feeding behavior. Digestion. 54:360-361.
55. Turton, M.D., D. O'Shea, I. Gunn, S.A. Beak, C.M.B. Edwards, K. Meeran, S.J. Choi, G.M. Taylor, M.M. Heath, P.D. Lambert, et al. 1996. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 379:69-72.
56. Tang-Christensen, M., P.J. Larsen, R. Goke, A. Fink-Jensen, D.S. Jessop, M. Moller, and S.P. Sheikh. 1996. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am. J. Physiol. 271:R848-R856.
57. Orskov, C., S.S. Poulsen, M. Moller, and J.J. Holst. 1996. Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. Diabetes. 45:832-835.
58. Kieffer, T.J., C.H.S. McIntosh, and R.A. Pederson. 1995. Degradation of glucose-dependent insulinotropic polypeptide (GIP) and truncated glucagon-like peptide1I (tGLP-1) in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology, 136:3585-3596.
59. Flint, A., A. Raben, J.J. Holst, and A. Astrup. 1997. Glucagon-like peptide-1 promotes satiety and suppresses energy intake in humans. Int. J. Obes. 21(Suppl. 2):28.
60. Kajimura, N., H. Iseki, R. Tanaka, C. Ohue, K. Otsubo, M. Gyoutoku, K. Sasaki, Y. Akiyama, and K. Yamaguchi. 1996. Toxohormones responsible for cancer cachexia syndrome in nude mice bearing human cancer cell lines. Cancer Chemother. Pharmacol. 38:S48-S52.
61. Simon, J.P., A.M. Schols, L.A. Campfield, E.F. Wouters, and W.H. Saris. 1997. Plasma-concentration of total leptin and human lung-cancer-associated cachexia. Clin. Sci. 93:273-277.
62. Morley, J.E. 1987. Neuropeptide regulation of appetite and weight. Endocr. Rev. 8:256-287.
63. White, J.D. 1993. Neuropeptide Y: a central regulator of energy homeostasis. Regul. Pept. 49:93-107.
64. Dryden, S., H. Frankish, Q. Wang, and G. Williams. 1994. Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? Eur. J. Clin. Invest. 24:293-308.
65. Frankish, H.M., S. Dryden, D. Hopkins, Q. Wang, and G. Williams. 1995. Neuropeptide Y. the hypothalamus, and diabetes: insights into the central control of metabolism. Peptides. 16:757-771.
66. Turton, M.P., D. O'Shea, and S.R. Bloom. 1997. Central effects of neuropeptide Y with emphasis on its role in obesity and diabetes. In Neuropeptide Y and Drug Development. L. Grundemar and S.R. Bloom. editors. Academic Press. San Diego. 15-39.
67. Vettor, R., N. Zarjevski, I. Cusin, F. Rohner-Jeanrenaud, and B. Jeanrenaud. 1994. Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia. 37: 1202-1208.
68. Larsen, P.J., D.S. Jessop, H.S. Chowdrey, S.L. Lightman, and J.D. Mikkelsen. 1994. Chronic administration of glucocorticoids directly upregulates prepro-neuropeptide Y and Y1-receptor mRNA levels in the arcuate nucleus of the rat. J. Neuroendocrinol. 6:153-159.
69. McKibbin, P.E., S.J. Cotton, D. McCarthy, and G. Williams. 1992. The effect of dexamethasone on neuropeptide Y concentration in specific hypothalamic regions. Life Sci. 51:1301-1307.
70. Ponsalle, P., L.S. Srivastava, R.M. Uht, and J.D. White. 1992. Glucocorticoids are required for food deprivation-induced increases in hypothalamic neuropeptide Y expression. J. Neuroendocrinol. 4:585-591.
71. Morgan, D.G.A., P.D. Lambert, D.M. Smith, J.P.H. Wilding, and S.R. Bloom. 1946. Reduced NPY induced feeding in diabetic but not steroid-treated rats: lack of evidence for changes in receptor number or affinity. J. Neuroendocrinol. 8:283-290.
72. Dunhar, J.C., E. Ergene, and R.A. Barraco. 1992. Neuropeptide Y-stimulation of insulin secretion is mediated via the nucleus tractus solitarius. Horm. Metab. Rex. 24:103-105.
73. Williams, G., J.H. Stell, H. Cardoso, M.A. Ghatei, Y.C. Lee, J.S. Gill, J.M. Burrin, J.M. Polak, and S.R. Bloom. 1988. Increased hypothalamic neuropeptide Y concentrations in diabetic rat. Diabetes. 37:763-772.
74. Woods, S.C., E.C. Lotter, D.L. McKay, and D. Porte. 1979. Chronic intracerebroventricular infusions of insulin reduces food intake and body weight of baboons. Nature. 282:503-505.
75. Strubbe, J.H., and C.G. Mein. 1977. Increased feeding in response to bilateral injections of insulin antibodies in the VMH. Physiol. Behav. 19:309-313.
76. McCarthy, H.D., P.E. McKibbin, A.V. Perkins, E.A. Linton, and G. Williams. 1993. Alterations in hypothalamic NPY and CRF in anorexic tumor-bearing rats. Am. J. Physiol. 264:E638-E643.
77. Chance, W.T., A. Balasubramaniam, S. Sheriff, and J.E. Fischer. 1994. Possible role of neuropeptide Y in experimental cancer anorexia. Adv. Exp. Med. Biol. 354:185-201.
78. O'Shea, D., I. Gunn, X.H. Chen, S. Bloom, and J. Herbert. 1996. A role for central glucagon-like peplide-1 in temperature regulation. Neuroreport. 7: 830-832.